Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
5 p, 584.6 KB Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice / Pujol-Autonell, Irma (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ampudia, Rosa M. (Institut Germans Trias i Pujol) ; Monge, Pau (Institut Germans Trias i Pujol) ; Lucas, Anna M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Carrascal, Jorge (Universitat de Lleida) ; Verdaguer, Joan (Universitat de Lleida) ; Vives Pi, Marta (Institut Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Type 1 diabetes is a metabolic disease caused by autoimmunity towards β -cells. Different strategies have been developed to restore β -cell function and to reestablish immune tolerance to prevent and cure the disease. [...]
2013 - 10.1155/2013/346987
ISRN Endocrinology, Vol. 2013 (march 2013)  
2.
5 p, 495.6 KB Breaking Therapeutic Inertia in Type 2 Diabetes : Active Detection of In-Patient Cases Allows Improvement of Metabolic Control at Midterm / Lucas Martín, Anna M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Guanyabens, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Zavala-Arauco, R. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Chamorro, Joaquín (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Granada, Maria Luisa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Puig Domingo, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Mauricio Puente, Dídac (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona. Departament de Medicina
Type 2 diabetes (T2D) exists in 25-40% of hospitalized patients. Therapeutic inertia is the delay in the intensification of a treatment and it is frequent in T2D. The objectives of this study were to detect patients admitted to surgical wards with hyperglycaemia (HH; fasting glycaemia > 140 mg/dL) as well as those with T2D and suboptimal chronic glycaemic control (SCGC) and to assess the midterm impact of treatment modifications indicated at discharge. [...]
2015 - 10.1155/2015/381415
International Journal of Endocrinology, Vol. 2015 (may 2015)  
3.
5 p, 584.6 KB Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice / Pujol-Autonell, Irma (Institut Germans Trias i Pujol. Banc de Sang i Teixits) ; Ampudia, Rosa Maria (Institut Germans Trias i Pujol. Banc de Sang i Teixits) ; Monge, Pau (Institut Germans Trias i Pujol. Banc de Sang i Teixits) ; Lucas, Anna M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Carrascal, Jorge (Institut de Recerca Biomèdica de Lleida) ; Verdaguer, Joan (Institut de Recerca Biomèdica de Lleida) ; Vives Pi, Marta (Institut Germans Trias i Pujol. Banc de Sang i Teixits)
Type 1 diabetes is a metabolic disease caused by autoimmunity towards β -cells. Different strategies have been developed to restore β -cell function and to reestablish immune tolerance to prevent and cure the disease. [...]
2013
ISRN Endocrinology, Vol. 2013 (march 2013)  

See also: similar author names
1 Lucas, A
3 Lucas, A. M.
3 Lucas, A.M.
1 Lucas, Andrew
1 Lucas, Anna
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.